Company Overview
American Healthcare Capital is pleased to exclusively introduce an innovative medical and fitness equipment developer, manufacturer, and distributor of non-invasive spine care products. The Company’s current flagship product is a patented, FDA-cleared multi-purpose therapeutic device and proof of concept for the treatment of patients suffering from severe low back pain and is utilized by Pain Management Centers, Orthopedic Hospitals, Sports Medicine, Physical Therapists, and Chiropractors in over 14 countries.
The next generation of “fully self-operated fitness and rehabilitation devices” will focus on (1) a user-friendly device for gyms, homes, and offices that allows for complete 3-D stretching, myofascial release, and core muscle strengthening, and (2) clinician-assisted assessment and treatment in a device that provides spinal flexion, extension, rotation, strengthening, and myofascial release. Both products can improve spinal function to prevent or reduce pain and stiffness and improve well-being.
Financial Overview
The Company’s MedTech Devices focus on alleviating back pain. The global Fitness Equipment Market is valued at USD 13.8 Billion in 2022 and is projected to reach a value of USD 20.6 Billion by 2030 at a CAGR (Compound Annual Growth Rate) of 5.1% between 2023 & 2030. Fitness equipment is used for performing exercises related to physical well-being, weight management, and improving a person’s muscular strength and body stamina. Additionally, the sports and fitness industry in the U.S. is also impacted significantly by lower back pain, as approximately 20% of all injuries involve lower back and neck injuries.
The Company is developing two “next generation” Therapeutic Sports, Health and Fitness MedTech devices. This will significantly impact the core foundations of athletic and patient care, including physical therapy, sports medicine, fitness and performance, and the wellness sector. The Company’s current Proof of Concept device has been utilized during many sporting events for nearly 5 years by the PGA/USGA for the purpose of the USOPEN. The Company has engaged with professional athletes, athletic trainers, physical therapists and medical doctors of teams involving NFL, NHL, NBA, MLB and USTA. The next generation fitness technologies device will improve athletic health and performance, injury recovery, and facilitate injury prevention. The Sports & Fitness devices will be used for targeted stretching and exercising of specific muscle groups to increase flexibility, mobility, and strength. Performance is enhanced and posture is improved through stretching.
The Next Generation devices are forecasted to launch in 2026 and 2027. The new devices under development have lower, more competitive price points, advanced technology with lower costs to produce resulting in much higher gross profit margins. The channels of distribution for these market segments for the Therapeutic Sports and Commercial Fitness Devices are huge with expected coverage in occupational health, physical therapy settings, rehab centers and all areas of wellness, sports and fitness, as well as high-traffic areas of malls and airports.
The Ask
The Company is seeking $10 million of growth capital for the development and launch of 2 next-generation products.
The company is looking for a strategic or equity buyer who can help implement its brand into the global markets by taking advantage of the enormous upside potential in the pain management and fitness & sports devices market. Therefore, the Owners will consider either growth funding of $10 million or a majority equity investment while remaining with the Company to implement the growth opportunities.
Price Is to Be Determined with or without an Earnout Going Forward.
